Yangming Ding

Investigation of Metal-Organic Framework-5 (MOF-5) as an Antitumor Drug Oridonin Sustained Release Carrier

Yingchao Yu, Xiaoxv Dong, Xingbin Yin, 2019, Molecules.

Superior Efficacy of a TBI-166, Bedaquiline, and Pyrazinamide Combination Regimen in a Murine Model of Tuberculosis

Yu Lu, L. Fu, Bin Wang, 2022, Antimicrobial agents and chemotherapy.

Effects of ABCG2 and SLCO1B1 gene variants on inflammation markers in patients with hypercholesterolemia and diabetes mellitus treated with rosuvastatin

Wenwen Du, Wenyu Xin, Pengmei Li, 2020, European Journal of Clinical Pharmacology.

Scission of C–O and C–C linkages in lignin over RuRe alloy catalyst

Changzhi Li, Xiaoli Pan, Xiaoyan Liu, 2021, Journal of Energy Chemistry.

Relevance of gene polymorphisms of NAT2 and NR1I2 to anti-tuberculosis drug-induced hepatotoxicity

Xinting Yang, Xiaoyou Chen, Xi Chen, 2022, Xenobiotica; the fate of foreign compounds in biological systems.

Efficacy of Replacing Linezolid with OTB-658 in Anti-Tuberculosis Regimens in Murine Models

Yu Lu, L. Fu, Bin Wang, 2023, Antimicrobial agents and chemotherapy.